Global Animal Medicine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Animal Medicine Market Research Report 2024
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
According to MRAResearch’s new survey, global Animal Medicine market is projected to reach US$ 33280 million in 2033, increasing from US$ 23520 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Medicine market research.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Segment by Type
Oral
Injection
Other
Companion Animals
Livestock Animals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Animal Medicine market is projected to reach US$ 33280 million in 2033, increasing from US$ 23520 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Medicine market research.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Segment by Type
Oral
Injection
Other
Segment by Application
Companion Animals
Livestock Animals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source